Recent Finacing
Recent Raise
Abterra Biosciences is a CRO that uses next-generation sequencing, mass spectrometry, and machine learning to map antibody responses and identify therapeutic antibodies for oncology drug discovery.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at Abterra Biosciences.
